Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosis.

Authors:
Xie L; Chen J; Hu H; Zhu Y; Wang X and 3 more

Journal:
Bioact Mater

Publication Year: 2024

DOI:
10.1016/j.bioactmat.2024.02.015

PMCID:
PMC10881364

PMID:
38390527

Journal Information

Full Title: Bioact Mater

Abbreviation: Bioact Mater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare no competing financial interest."

Evidence found in paper:

"Funding This study was supported by the 10.13039/501100001809National Natural Science Foundation of China (Grant 82070251 to M.X.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025